DBV Technologies - ADR Live Stock Price Today, Share Analysis and Chart

Name: DBV Technologies - ADR: Is Infosys Ltd. worth buying?
Item: DBV Technologies - ADR
Rating: 1.94083325
Author: Trendlyne DVM scores

about

DBV Technologies SA is a clinical-stage specialty biopharmaceutical company focused on changing the field of immunotherapy by developing a novel technology platform called Viaskin. The therapeutic approach is based on epicutaneous immunotherapy or EP...

9.54 -0.26 (-2.65%)

25.35% Fall from 52W High

24,781

XNAS Volume

XNAS 21 Aug, 2025 5:30 PM (EDT)

Not Eligible

Expensive Valuation

6.8 / 100

Technically Bullish

70.8 / 100

No estimates available

DBV Technologies - ADR Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

DBV Technologies - ADR Live Stock Price Today, Share Analysis and Chart

DBV Technologies SA is a clinical-stage specialty biopharmaceutical company focused on changing the field of immunotherapy by developing a novel technology platform called Viaskin. The therapeutic approach is based on epicutaneous immunotherapy or EP...

25.35% Fall from 52W High

SWOT Analysis

DBV Technologies - ADR Live Price Chart